• Users Online: 1671
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
ARTICLE
Year : 2012  |  Volume : 3  |  Issue : 4  |  Page : 153-158

Current Concepts in Lymphoma Biology: Effect on Management and Outcome


1 Section of Medical Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Date of Web Publication23-Jun-2014

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions
  Abstract 

The understanding of the pathobiology of lymphomas has improved significantly over the past 2 decades. This development has led to multiple revisions in the lymphoma classification of the International Working Formulation through French-American-British and Revised European American Lymphoma (REAL) to the most recent modification of the World Health Organization (WHO) lymphoma classification1. The most recent modification of the WHO lymphoma classification lists approximately 100 subtypes of lymphoid malignancy2. Although there have been improvements in the management and outcomes of patients, there has been a significant lag in the individualization of therapies for different types of lymphomas. For instance, Fisher et al. reported in 1992 that cyclophosphamide, hydroxyadriamycin, vincristine, prednisone (CHOP) therapy was the standard of care for all diffuse large B-cell lymphomas (DLBCL)3. A decade later, European investigators (Coiffier et al. and Pfreundschuh et al.) reported outcome improvements in DLBCL patients following the addition of an anti-CD20 antibody to standard CHOP chemotherapy4,5. However, several investigators reported that all DLBCLs are not created equal6-8. A decade later, we still do not know how best to approach germinal center B-cell (GCB) vs. activated B-cell (ABC) types of DLBCL. A detailed discussion of the new understanding of lymphoma biology and management is beyond the scope of this report. We will, however, attempt to focus on some of the more important advances related to the pathology and management of lymphomas that have come forth in the past decade.


How to cite this article:
Maghfoor I, Akhtar S, Bakshi N. Current Concepts in Lymphoma Biology: Effect on Management and Outcome. J Appl Hematol 2012;3:153-8

How to cite this URL:
Maghfoor I, Akhtar S, Bakshi N. Current Concepts in Lymphoma Biology: Effect on Management and Outcome. J Appl Hematol [serial online] 2012 [cited 2021 Oct 21];3:153-8. Available from: https://www.jahjournal.org/text.asp?2012/3/4/153/135171

.




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract

 Article Access Statistics
    Viewed1316    
    Printed54    
    Emailed0    
    PDF Downloaded163    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]